Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Figure 1

Case 1. Serial contrast-enhanced CT scans of the chest. (a) one month after erlotinib therapy; (b) CT showing an increase in size of the lung nodule after 12 months of erlotinib therapy; (c) CT showing a stable disease of the lung nodule after two cycles of chemotherapy; (d) CT showing a shrinkage of the tumor in the right lower lobe after 4 weeks of erlotinib re-challenge.

Back to article page